Pingkian, Portia Scharllet .
HRN: 25-97-95 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/10/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/10/2025
01/17/2025
INTRAVENOUS
900 Mg
Every 6 Hours
PCAP-C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes